Switch to:
Valeant Pharmaceuticals International Inc (NYSE:VRX)
Cash from Financing
$1,908 Mil (TTM As of Jun. 2014)

Cash from financing is the cash generated/spent from financial activities such as share issuance (buy back), debt issuance (repayment), and dividends paid to preferred and common stockholders.

For the three months ended in Jun. 2014, Valeant Pharmaceuticals International Inc paid $0 Mil more to buy back shares than it received from issuing new shares. It spent $74 Mil paying down its debt. It paid $0 Mil more to buy back preferred shares than it received from issuing preferred shares. It received $0 Mil from paying cash dividends to shareholders. It spent $83 Mil on other financial activities. In all, Valeant Pharmaceuticals International Inc spent $157 Mil on financial activities for the three months ended in Jun. 2014.


Definition

This is the cash generated/spent from financial activities such as share issuance (buy back), debt issuance (repayment), and dividends paid to preferred and common stockholders. In the calculation of free cash flow, cash from financing is not calculated because it is not related to operating activities.

Valeant Pharmaceuticals International Inc's Cash from Financing for the fiscal year that ended in Dec. 2013 is calculated as:

Cash from Financing(A: Dec. 2013 )
=Net Issuance of Stock+Net Issuance of Debt+Net Issuance of Preferred+Dividends+Other Financing
=2251.807+2067.41+0+0+-291.465
=4,028

Valeant Pharmaceuticals International Inc's Cash from Financing for the quarter that ended in Jun. 2014 is

Valeant Pharmaceuticals International Inc Cash Flow from Financing for the trailing twelve months (TTM) ended in Jun. 2014 was 2318.478 (Sep. 2013 ) + -130.888 (Dec. 2013 ) + -122.7 (Mar. 2014 ) + -156.6 (Jun. 2014 ) = $1,908 Mil.

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.


Explanation

Cash from financing contains five items:

1. Net Issuance of Stock:
A company may raise cash from issuing new shares. It can also use cash to buy back shares. If this number is positive, it means that the company has received more cash from issuing shares than it has paid to buy back shares. If this number is negative, it means that company has paid more cash to buy back shares than it has received for issuing shares.

Valeant Pharmaceuticals International Inc's net issuance of stock for the three months ended in Jun. 2014 was $0 Mil. Valeant Pharmaceuticals International Inc paid $0 Mil more to buy back shares than it received from issuing new shares.

2. Net Issuance of Debt:
Net issuance of debt is the cash a company received or spent through debt related activities such as debt issuance or debt repayment. If a company pays down its debt during the period, this number will be negative. If a company issued more debt, it receives cash and this number is positive.

Valeant Pharmaceuticals International Inc's net issuance of debt for the three months ended in Jun. 2014 was $-74 Mil. Valeant Pharmaceuticals International Inc spent $74 Mil paying down its debt.

3. Net Issuance of Preferred:
A company may raise cash from issuing new preferred shares. It can also use cash to buy back preferred shares. If this number is positive, it means that the company has received more cash from issuing preferred shares than it has paid to buy back preferred shares. If this number is negative, it means that company has paid more cash to buy back preferred shares than it has received for issuing preferred shares.

Valeant Pharmaceuticals International Inc's net issuance of preferred for the three months ended in Jun. 2014 was $0 Mil. Valeant Pharmaceuticals International Inc paid $0 Mil more to buy back preferred shares than it received from issuing preferred shares.

4. Dividends:
Cash flow for dividends refers to the payment of cash to shareholders as dividends when the company generates income.

Valeant Pharmaceuticals International Inc's cash flow for dividends for the three months ended in Jun. 2014 was $0 Mil. Valeant Pharmaceuticals International Inc received $0 Mil from paying cash dividends to shareholders.

5. Other Financing:
Money spent or earned by company from other financial activities.

Valeant Pharmaceuticals International Inc's other financing for the three months ended in Jun. 2014 was $-83 Mil. Valeant Pharmaceuticals International Inc spent $83 Mil on other financial activities.


Related Terms

Cash Flow from Operations, Cash Flow from Investing, Net Issuance of Stock, Net Issuance of Debt, Dividends, Net Issuance of Preferred


Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.

Valeant Pharmaceuticals International Inc Annual Data

Dec04Dec05Dec06Dec07Dec08Dec09Dec10Dec11Dec12Dec13
Net Issuance of Stock 831611-301-2-598-2812,252
Net Issuance of Debt -346-40-26-41803242012,7713,4712,067
Net Issuance of Preferred 0000000000
Dividends 0-80-80-322-180-147-356-5200
Other Financing 4-3-1-0-0-0-56-173-133-291
Cash from Financing -335-119-92-729-210177-2131,9483,0574,028

Valeant Pharmaceuticals International Inc Quarterly Data

Mar12Jun12Sep12Dec12Mar13Jun13Sep13Dec13Mar14Jun14
Net Issuance of Stock -104-17200-352,251-13800
Net Issuance of Debt 346504332,587-4271692,364-38-77-74
Net Issuance of Preferred 0000000000
Dividends 0000000000
Other Financing -32-40-41-25-54-63-44-131-46-83
Cash from Financing 210292-82,562-5162,3562,318-131-123-157
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK